Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Leases (2021 - 2022)

Historic Leases for Atea Pharmaceuticals (AVIR) over the last 2 years, with Q3 2022 value amounting to $2.5 million.

  • Atea Pharmaceuticals' Leases rose 101277.53% to $2.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $2.5 million, marking a year-over-year increase of 101277.53%. This contributed to the annual value of $161000.0 for FY2021, which is N/A changed from last year.
  • Atea Pharmaceuticals' Leases amounted to $2.5 million in Q3 2022, which was up 101277.53% from $2.7 million recorded in Q2 2022.
  • In the past 5 years, Atea Pharmaceuticals' Leases registered a high of $2.9 million during Q1 2022, and its lowest value of $161000.0 during Q4 2021.